| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine
|
Goldberg, Ronald B.
|
|
1995
|
76 |
1-2S1 |
p. 107A-109A
nvt p.
|
artikel
|
| 2 |
Changes in plasmaapolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine
|
Bard, Jean-Marie
|
|
1995
|
76 |
1-2S1 |
p. 65A-70A
nvt p.
|
artikel
|
| 3 |
Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patients
|
Teramoto, Tamio
|
|
1995
|
76 |
1-2S1 |
p. 33A-36A
nvt p.
|
artikel
|
| 4 |
Clinical efficacy of fluvastatin in thelong-term treatment of familial hypercholesterolemia
|
Koizumi, Junii
|
|
1995
|
76 |
1-2S1 |
p. 47A-50A
nvt p.
|
artikel
|
| 5 |
Clustering of cardiovascular risk factors: Targeting high-risk individuals
|
Genest Jr., Jacques
|
|
1995
|
76 |
1-2S1 |
p. 8A-20A
nvt p.
|
artikel
|
| 6 |
Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia
|
Jacotot, Bernard
|
|
1995
|
76 |
1-2S1 |
p. 54A-56A
nvt p.
|
artikel
|
| 7 |
Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine
|
Holdaas, Hallvard
|
|
1995
|
76 |
1-2S1 |
p. 102A-106A
nvt p.
|
artikel
|
| 8 |
Effect of fluvastatin on intermediatedensity Lipoprotein (remnants) and other lipoprotein levels in hypercholestarolemia
|
Broyles, Frances E.
|
|
1995
|
76 |
1-2S1 |
p. 129A-135A
nvt p.
|
artikel
|
| 9 |
Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin
|
Smit, Jan W.A.
|
|
1995
|
76 |
1-2S1 |
p. 89A-96A
nvt p.
|
artikel
|
| 10 |
Effects of fluvastatin on humanbiliary lipids
|
Tazuma, Susumu
|
|
1995
|
76 |
1-2S1 |
p. 110A-113A
nvt p.
|
artikel
|
| 11 |
Effects of fluvastatin on lipid profile andapolipoproteins in Chinese patients with hypercholesterolemia
|
Tomlinson, Brian
|
|
1995
|
76 |
1-2S1 |
p. 136A-139A
nvt p.
|
artikel
|
| 12 |
Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro
|
Rogler, Gerhard
|
|
1995
|
76 |
1-2S1 |
p. 114A-116A
nvt p.
|
artikel
|
| 13 |
Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia
|
Milani, Massimo
|
|
1995
|
76 |
1-2S1 |
p. 51A-53A
nvt p.
|
artikel
|
| 14 |
Efficacy and safety of triple therapy(fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia
|
Leitersdorf, Eran
|
|
1995
|
76 |
1-2S1 |
p. 84A-88A
nvt p.
|
artikel
|
| 15 |
Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coeezyme a reduefase inhibitor
|
Zavoral, James H.
|
|
1995
|
76 |
1-2S1 |
p. 37A-40A
nvt p.
|
artikel
|
| 16 |
Fluvastatin for dyslipoproteinemia,with or without concomitant chronic renal insufficiency
|
Lintott, Caroline J.
|
|
1995
|
76 |
1-2S1 |
p. 97A-101A
nvt p.
|
artikel
|
| 17 |
Fluvastatin in severe hypercholesterolemia:Analysis of a clinical trial database
|
Peters, Tim K.
|
|
1995
|
76 |
1-2S1 |
p. 71A-75A
nvt p.
|
artikel
|
| 18 |
Health and economic issues in theprevention of coronary artery disease
|
Hogan, Thomas
|
|
1995
|
76 |
1-2S1 |
p. 140A-142A
nvt p.
|
artikel
|
| 19 |
High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemia
|
Eliav, Osnat
|
|
1995
|
76 |
1-2S1 |
p. 76A-79A
nvt p.
|
artikel
|
| 20 |
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
|
Eichstädt, Hermann W.
|
|
1995
|
76 |
1-2S1 |
p. 122A-125A
nvt p.
|
artikel
|
| 21 |
Introduction
|
Schonfeld, Gustav
|
|
1995
|
76 |
1-2S1 |
p. 1A-2A
nvt p.
|
artikel
|
| 22 |
Is endothelial dysfunction reversible?
|
Schmieder, Roland E.
|
|
1995
|
76 |
1-2S1 |
p. 117A-121A
nvt p.
|
artikel
|
| 23 |
Lack of interaction between fluvastatin andoral nypoylycemie agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus
|
Appel, Silke
|
|
1995
|
76 |
1-2S1 |
p. 29A-32A
nvt p.
|
artikel
|
| 24 |
Lipid risk factors and the regression of atherosclerosis
|
Gotto Jr., Antonio M.
|
|
1995
|
76 |
1-2S1 |
p. 3A-7A
nvt p.
|
artikel
|
| 25 |
Long-term efficacy with fluvastatinas monotherapy and combined with cholestyramine (A 156-week multicenter study)
|
Jacotot, Bernard
|
|
1995
|
76 |
1-2S1 |
p. 41A-46A
nvt p.
|
artikel
|
| 26 |
Open-label study to assess the efficacy, safe, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia
|
Fanghänel, Guillermo
|
|
1995
|
76 |
1-2S1 |
p. 57A-61A
nvt p.
|
artikel
|
| 27 |
Outcome monitoring of fluvastatin in a Department of Veterans Affairs Lipid Clinic
|
Kellick, Kenneth A.
|
|
1995
|
76 |
1-2S1 |
p. 62A-64A
nvt p.
|
artikel
|
| 28 |
Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
|
Corsini, Alberto
|
|
1995
|
76 |
1-2S1 |
p. 21A-28A
nvt p.
|
artikel
|
| 29 |
Pharmacokinetics of the combination of fluvastatin and gemfibrozil
|
David Spence, J.
|
|
1995
|
76 |
1-2S1 |
p. 80A-83A
nvt p.
|
artikel
|
| 30 |
Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage
|
Smit, Jan W.A.
|
|
1995
|
76 |
1-2S1 |
p. 126A-128A
nvt p.
|
artikel
|
Tijdschrift beschrijving